Carna Biosciences (TSE:4572) Additional Paid-In Capital : 円5,828 Mil(As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Carna Biosciences Additional Paid-In Capital?

Carna Biosciences's quarterly additional paid-in capital stayed the same from Sep. 2023 (円5,828 Mil) to Dec. 2023 (円5,828 Mil) and stayed the same from Dec. 2023 (円5,828 Mil) to Mar. 2024 (円5,828 Mil).

Carna Biosciences's annual additional paid-in capital increased from Dec. 2021 (円4,808 Mil) to Dec. 2022 (円5,133 Mil) and increased from Dec. 2022 (円5,133 Mil) to Dec. 2023 (円5,828 Mil).

Carna Biosciences Additional Paid-In Capital Historical Data

The historical data trend for Carna Biosciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carna Biosciences Additional Paid-In Capital Chart

Carna Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

3,475.49

4,310.04

4,808.16

5,133.46

5,827.68

Carna Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															5,775.19	5,803.82	5,827.68	5,827.68	5,827.68

Carna Biosciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Carna Biosciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Carna Biosciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Carna Biosciences (TSE:4572) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Carna Biosciences Inc (TSE:4572) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047

Website

http://www.carnabio.com

Carna Biosciences, Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines primarily for the treatment of cancer and inflammatory diseases using own innovative kinase drug discovery platform, QuickScout.

Carna Biosciences (TSE:4572) Headlines

No Headlines